New device offers hope for stem cell transplant patients with poor graft function
NCT ID NCT02438904
First seen Nov 12, 2025 · Last updated Jun 18, 2026 · Updated 31 times
Summary
This study provides compassionate access to a device that selects CD34+ cells (special blood-forming cells) for patients whose stem cell transplant did not work well. The goal is to improve graft function and monitor for graft-versus-host disease. Up to 200 participants will receive this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD AND MARROW TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.